mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant

(2022) Na-Na Zhang et al.   CELL RESEARCH

A guide to immunotherapy for COVID-19

(2022) Frank L. van de Veerdonk et al.   NATURE MEDICINE

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses

(2022) Benjamin L. Sievers et al.   Science Translational Medicine

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

(2022) Yingdan Wang et al.   Emerging Microbes & Infections

Circular RNA vaccines against SARS-CoV-2 and emerging variants

(2022) Liang Qu et al.   CELL

From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases

(2021) Emily H. Pilkington et al.   Acta Biomaterialia

COVID-19 vaccines

(2021) Duduzile Ndwandwe et al.   CURRENT OPINION IN IMMUNOLOGY

mRNA Vaccines in the COVID-19 Pandemic and Beyond

(2021) Michael J. Hogan et al.   Annual Review of Medicine

Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine

(2021) Richard B Kennedy   LANCET

The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant

(2021) Changjing Cai et al.   MOLECULAR THERAPY